HMGCR and rheumatoid arthritis: Nevertheless, in terms of lipid-lowering drug targets, the genetically proxied HMGCR inhibition equivalent to LDL-C decrease was causally associated with a lower risk of RA, SMR analysis also supported the presence of an association between HMGCR gene suppression and RA.